- AcuityMD is an AI-driven MedTech intelligence platform based in Atlanta, Georgia, valued at $955 million, serving 16 of the top 20 MedTech companies globally and facilitating over $34 billion in identified commercial pipeline opportunities.
- In April 2026, AcuityMD raised $80 million in a Series C funding round led by StepStone Group, bringing total funding to over $160 million to enhance its AI capabilities and expand its platform.
- The platform connects real-time market data with company-specific context, enabling commercial teams at major MedTech firms to generate targeted insights and improve sales execution.
- AcuityMD's ideal buyers are commercial teams within MedTech companies seeking to streamline their research processes and enhance market intelligence, making it a critical tool for improving sales and marketing effectiveness in a competitive landscape.
Acuity's workforce is organized into ten distinct departments, with Operations leading in headcount at 16 employees, followed by Information Technology with 9 and Executive at 7. This distribution indicates a strong emphasis on operational efficiency and technological support, essential for sustaining business functions in the electronics sector. The presence of smaller departments such as Engineering and Education reflects a balanced approach to innovation and workforce development.
The company's workforce is distributed across 11 locations, with the highest concentration in Reston, VA, housing 8 employees, followed closely by Washington, D.C., with 7. The presence of a significant 'Other' category, comprising 37 employees, suggests a distributed workforce model, likely involving remote roles or smaller offices. This geographic spread indicates Acuity's strategic positioning to leverage talent across various regions while maintaining a centralized operational focus in key areas.
